Therefore, targeting BAP1 by its inhibitors such as iBAP-II or in combination with other therapeutic strategies might be an effective treatment strategy for human neuroblastomas with amplified MYCN which warrants further in deep investigation. This evidence concerns the gene MYCN and neuroblastoma.